ACADIA Pharmaceuticals Inc. vs Snap On Incorporated — how do they compare? ACADIA Pharmaceuticals Inc. trades at $29.52 (market cap $5.07B), while Snap On Incorporated trades at $410.51 (market cap $21.30B). The key difference: Snap On Incorporated is far larger — about 4.2× ACADIA Pharmaceuticals Inc.'s market cap, and Snap On Incorporated pays a 2.37% dividend while ACADIA Pharmaceuticals Inc. pays none. Which is the better fit depends on your goals.
| ACAD | SNA | |
|---|---|---|
Market Cap | $5.07B | $21.30B |
Sector | Health | Technology |
52-Week High | $29.41 | $419.31 |
52-Week Low | $20.06 | $321.38 |
Enterprise Value | $4.19B | $20.93B |
Dividend Yield | — | 2.37% |
Trailing returns across standard periods
Latest headlines on both assets
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →Snap-on Incorporated is a leading global innovator, manufacturer, and marketer of tools, equipment, diagnostics, repair information, and systems solutions for professional users. Its products are widely used in vehicle service and repair, as well as in other demanding industrial environments. The company is best known for its premium tool brand, often sold through a network of franchised mobile stores, and is a primary supplier to technicians in the transportation industry.
Read more on SNA →